Expression of interleukin 2 receptors on activated human B cells
about
Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytesIdentification of a cDNA for a human high-molecular-weight B-cell growth factorHuman interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequencesGuidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapyInterleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene.Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro.Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.A simple guide to the terminology and application of leucocyte monoclonal antibodies.Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis.The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor.Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.Interleukin 6 gene expression in normal and neoplastic B cells.The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferationCpG methylation changes within the IL2RA promoter in type 1 diabetes of childhood onset.On the role of sIL-2R measurements in rheumatoid arthritis and cancers.Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7Cytokines in inflammatory bowel disease.B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytesPro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 casesDevelopment of plasmacytoid cells with Russell bodies in autoimmune "viable motheaten" mice.A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.Bladder Cancer Immunotherapy: BCG and Beyond.Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferationImmunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsivenessTerminal maturation of resting B cells by proliferation-independent B cells differentiation factors.The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells.Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria.Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicityIL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts.The immunotherapy of human cancer with interleukin 2: present status and future directions.
P2860
Q24298467-CE4AC92D-3A85-4E31-8E3E-CC7A8F0A6B72Q24309517-A0CAF320-61F1-41C6-BFDF-F76804967D59Q24558671-40FEC257-7CC0-4257-8958-25CA80A7903FQ28731819-D8317EBD-E5CC-4B26-BB57-0F097FDDD35FQ33578516-C38D598E-2B41-4A98-957E-02C1AA3D4E1AQ33611936-AA10C9CC-9780-4FAE-83C3-C4A4B6F56E74Q33645011-C99B27CF-DDFB-43A5-BA72-333977A3E3F6Q33861934-74C1B821-FE9D-4C98-A5A8-26E56DED6CE2Q34115915-5D6E5791-F318-4FB8-95C2-A510494E3564Q34172760-A2F4282E-D4E0-440F-B555-641213F54EFAQ34292553-3E4D8BA0-9370-4E0A-9D24-91F5418461D7Q34334821-39C80008-B7FF-456D-B36E-536E7458B44DQ34392919-1EAAFE8A-FF44-4A9B-85A0-480B17E1E820Q34416149-AD285020-D990-4BA0-BA31-14E8253353E8Q34528269-FFF44F5F-A508-4E27-A82E-AE9886430606Q34572044-89D4BE55-BE69-4A6E-BA27-B0F1BC85CA54Q34659968-BC73A758-E973-4851-B26F-EBA8972822A1Q34846677-61B94292-8B17-4F61-A266-9ED61415ABA1Q34894394-565479A0-4C9C-492C-B771-6F221EB7BC1FQ34979517-04C8F8F2-6A10-4FC5-90A3-DAE3E5921B33Q35357417-0C7F4483-C57F-4D04-A917-1E8A116FA5FEQ35556914-132C6E6F-D8E8-4F41-88B3-40E40AE7C19CQ35576711-4C5E9990-D084-445C-9CF1-9611410A8AE9Q35698637-55323F73-7EEF-4EEE-8842-3A37AEE4E5BAQ35818386-DD535023-45DD-43D6-A292-0EC11072C96DQ35855947-83F60F1B-4F60-41E7-A52D-1CE09E29F6BBQ35855981-344D75F1-878E-472E-8E69-1F1F4A333BBFQ35976681-C5388181-28F9-428E-BE57-1B6B305DA0D0Q35994118-779FEC87-3D46-4D88-8501-65A28D7B3DCFQ36072179-87ADA1C8-24F2-4ECF-B549-EC19E4B2BA36Q36292676-434842CA-A587-4B2D-BC25-4A414B96023FQ36350305-1505ABF1-B6A7-4F58-8AD6-37C541285F0DQ36350373-E4A77CB9-EFD0-47ED-A632-D5A51A3ABF61Q36352314-2243AA75-A111-4896-8350-C66387201A9DQ36354704-557A3B3F-630D-410B-A31B-44B768A3720BQ36889622-DDD1C705-C96F-4E1F-B5B8-673CE7E5B798Q37017209-0983B2CE-3990-4799-B1C9-4558F73EDBB7Q37066127-45CBBE37-C7D8-49D0-B992-CAE6C799D6C4Q37370670-D812751F-FED3-4BD0-9DCF-9B5E84781FE1Q37427683-6061C032-96EA-4326-957F-CEE674214B07
P2860
Expression of interleukin 2 receptors on activated human B cells
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh
1984年學術文章
@zh-hant
name
Expression of interleukin 2 receptors on activated human B cells
@ast
Expression of interleukin 2 receptors on activated human B cells
@en
type
label
Expression of interleukin 2 receptors on activated human B cells
@ast
Expression of interleukin 2 receptors on activated human B cells
@en
prefLabel
Expression of interleukin 2 receptors on activated human B cells
@ast
Expression of interleukin 2 receptors on activated human B cells
@en
P2093
P2860
P356
P1476
Expression of interleukin 2 receptors on activated human B cells
@en
P2093
Bongiovanni KF
Goldman CK
Korsmeyer SJ
Leonard WJ
Sharrow SO
Waldmann TA
P2860
P304
P356
10.1084/JEM.160.5.1450
P407
P577
1984-11-01T00:00:00Z